MedTrace Logo

Safety and Effectiveness Study of a Fiber Supplement for Weight Loss

NCT00613600 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-12-02

No results posted yet for this study

Summary

Overweight and obesity are serious and growing problems within the United States. The usual approaches to weight loss-dieting, exercise, and behavioral interventions-rarely result in long-term weight loss. Therefore, we will evaluate the safety and efficacy of glucomannan, a fiber supplement that has promising weight loss effects.

Conditions

Interventions

DIETARY_SUPPLEMENT

Glucomannan

Two 665 mg capsules of glucomannan three times a day for 8 weeks

DIETARY_SUPPLEMENT

Inert microcrystalline cellulose

Two capsules of inert microcrystalline cellulose three times a day for eight weeks

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Joyce K Keithley, DNSc, RN · Rush University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-06-30
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00613600 on ClinicalTrials.gov